1. Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression
    Sara Franceschi et al, 2018, EBioMedicine CrossRef
  2. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway
    Lvfen Gao et al, 2018, Life Sciences CrossRef
  3. Modification to increase the thermostability and catalytic efficiency of α-L-rhamnosidase from Bacteroides thetaiotaomicron and high-level expression
    Changning Lu et al, 2022, Enzyme and Microbial Technology CrossRef
  4. Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK/mTOR signaling pathway
    Xueqiang Zhao et al, 2020, Anti-Cancer Drugs CrossRef
  5. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
    Christian Bailly, 2020, Chemico-Biological Interactions CrossRef
  6. Icaritin: A phytomolecule with enormous pharmacological values
    Nguyen Thi Huong et al, 2023, Phytochemistry CrossRef
  7. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer
    Zhuoqi Zhang et al, 2017, Pathology - Research and Practice CrossRef
  8. PHF6 mutation is associated with poor outcome in acute myeloid leukaemia
    Kexiu Huang et al, 2023, Cancer Medicine CrossRef
  9. Immobilization of Thermostable β-Glucosidase and α-l-Rhamnosidase from Dictyoglomus thermophilum DSM3960 and Their Cooperated Biotransformation of Total Flavonoids Extract from Epimedium into Icaritin
    Yurong Dong et al, 2021, Catalysis Letters CrossRef
  10. A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
    Haowen Li et al, 2020, Drug Delivery CrossRef
  11. MicroRNA‑25/ATXN3 interaction regulates human colon cancer cell growth and migration
    Dingyun Li et al, 2019, Molecular Medicine Reports CrossRef
  12. Kaposi Sarcoma–Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation
    Lu Dai et al, 2019, The Journal of Infectious Diseases CrossRef
  13. Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime
    Canjing Zhang et al, 2022, Molecular Therapy - Oncolytics CrossRef
  14. Clinico-pathological significance of Drp1 dysregulation and its correlation to apoptosis in oral cancer patients
    Aritri Ghosh et al, 2020, Mitochondrion CrossRef
  15. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan et al, 2024, Aging and disease CrossRef
  16. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway
    Lu Wang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. Linker-peptide-mediated one-step purification and immobilization of α-L-rhamnosidase from Bacteroides thetaiotaomicron for direct biotransformation from epimedin C to icariin
    Changning Lu et al, 2023, Enzyme and Microbial Technology CrossRef
  18. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
    Shikang Wang et al, 2019, Pharmaceutical Biology CrossRef
  19. Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis


    Chao Guo et al, 2020, Cancer Management and Research CrossRef
  20. Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
    Mukta Gupta et al, 2023, Phytotherapy Research CrossRef
  21. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
    Minglu Liu et al, 2022, Frontiers in Pharmacology CrossRef